Processing

Please wait...

Settings

Settings

1. WO1996002254 - SYNERGISTIC PHARMACEUTICAL COMPOSITONS CONTAINING 16$g(a),17$g(a)-ISOPROPYLIDENEDIOXY SUBSTITUTED PREGNANES

Considered void:  19.04.1995
Publication Number WO/1996/002254
Publication Date 01.02.1996
International Application No. PCT/SE1994/000693
International Filing Date 15.07.1994
IPC
A61K 31/58 2006.01
AHUMAN NECESSITIES
61MEDICAL OR VETERINARY SCIENCE; HYGIENE
KPREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
31Medicinal preparations containing organic active ingredients
56Compounds containing cyclopentahydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
58containing heterocyclic rings, e.g. aldosterone, danazol, stanozolol, pancuronium, digitogenin
CPC
A61K 31/58
AHUMAN NECESSITIES
61MEDICAL OR VETERINARY SCIENCE; HYGIENE
KPREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
31Medicinal preparations containing organic active ingredients
56Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives, e.g. steroids
58containing heterocyclic rings, e.g. danazol, stanozolol, pancuronium or digitogenin
Applicants
  • COHEN, Michel [SE/SE]; SE
Inventors
  • CHRIKI, Georges; IL
Agents
  • GÖTEBORGS PATENTBYRÅ AB; P.O. Box 5005 S-402 21 Göteborg, SE
Priority Data
Publication Language English (EN)
Filing Language English (EN)
Designated States
Title
(EN) SYNERGISTIC PHARMACEUTICAL COMPOSITONS CONTAINING 16$g(a),17$g(a)-ISOPROPYLIDENEDIOXY SUBSTITUTED PREGNANES
(FR) COMPOSITIONS PHARMACEUTIQUES SYNERGIQUES CONTENANT DES PREGNANES SUBSTITUES PAR 16$g(a),17$g(a)-ISOPROPYLIDENEDIOXY
Abstract
(EN)
A pharmaceutical composition comprises a synergistic combination of about 0.01-0.15 % by wt. triamcinolone acetonide and about 0.04-0.3 % by wt. halcinonide as active ingredients, in combination with a pharmaceutically acceptable carrier.
(FR)
Composition pharmaceutique comprenant une combinaison synergique d'environ 0,01 à 0,15 % en poids d'acétonide de triamcinolone ainsi qu'environ 0,04 à 0,3 % en poids d'halcinonide en tant que principes actifs, ainsi qu'un excipient acceptable sur le plan pharmacologique.
Also published as
Latest bibliographic data on file with the International Bureau